Stockreport

Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company's chief executive officer and chairman, will [Read more]